| 发明名称 |
ORAL PHARMACEUTICAL COMPOSITION OF METHYLERGONOVINE |
| 摘要 |
An oral modified release pharmaceutical composition of methylergonovine suitable for oral once daily administration is provided. The composition includes at least about 0.6 mg dose of methylergonovine or a pharmaceutically acceptable salt thereof and is particularly useful for treating migraine or refractory migraine. |
| 申请公布号 |
US2016339015(A1) |
申请公布日期 |
2016.11.24 |
| 申请号 |
US201615160831 |
申请日期 |
2016.05.20 |
| 申请人 |
Lupin Inc. |
发明人 |
Garegnani James;Nangia Avinash |
| 分类号 |
A61K31/48;A61K9/48;A61K9/24;A61K9/00;A61K9/20 |
主分类号 |
A61K31/48 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. An oral modified release pharmaceutical composition configured for once daily administration comprising at least about 0.6 mg methylergonovine or a pharmaceutically acceptable salt thereof. |
| 地址 |
Somerset NJ US |
